18F-FSPG PET/CT Imaging in Patients With Cancers

  • STATUS
    Recruiting
  • End date
    Dec 31, 2022
  • participants needed
    120
  • sponsor
    National Taiwan University Hospital
Updated on 23 February 2022
cancer
fdg pet
fludeoxyglucose f 18
primary malignant neoplasm

Summary

This study aims to compare the diagnostic performance of 18F-FDG and 18F-FSPG PET/CT in lung, breast, and abdominal cancers before undergoing therapy. In addition, the role of 18F-FSPG PET/CT in evaluating therapy response and prognosis will also be evaluated.

Details
Condition Pulmonary Cancer, Breast Neoplasms, Abdominal Cancer
Clinical Study IdentifierNCT03144622
SponsorNational Taiwan University Hospital
Last Modified on23 February 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients are given the opportunity to participate in the study if
Age 20 years old
Confirmed diagnosis of primary cancer of the following: NSCLC, breast or abdominal cancers
ECOG performance status 0 to 2
Life expectancy > 3 months
Consent to perform additional 18F-FSPG and 18F-FDG PET prior to therapy
Sexually active subjects agree to use condoms and/or their partners of reproductive potential to use a method of effective birth control during imaging period of 2 weeks

Exclusion Criteria

Patients with any of the following conditions will be excluded
Had received previous treatment (excluding neoadjuvant therapy)
Pregnant or lactating women
Known malignancy in other organs
Evaluated by primary care physician as unsuitable
Known hypersensitivity to the study drug
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note